Marketing & Strategy
Top tips for an award winning entry – Interview with Chair of Judges, PRIME Awards 2021

Marketing & Strategy: The PRIME Awards returns in 2021 to recognise and celebrate excellence within healthcare communications in the Australian pharmaceutical and life sciences industry.
In an interview with Health Industry Hub, media partner for the PRIME Awards, David Cousins, Chair of Judges, shares the highlights from last year and provides top tips for creating an award winning entry across 19 categories within healthcare communications.
Watch the interview below to hear from David on the following:
- Importance of celebrating outstanding innovations and excellence in healthcare communications.
- Features of an award-winning entry and how to differentiate your entry from others in the same category.
- Demonstrating the initiative / campaign impact.
- Entry success based on company size and campaign budget.
About David Cousins
David Cousins is a highly experienced business, brand and communications strategist and the Managing Director of The Cousins Consultancy.
With a wealth of strategic experience at global, regional and local market levels, he specialises in the transformation of health.
As the Chair of Judges, his goal is to ensure the PRIME Awards provide a strong platform for the recognition of excellence, and that the programme reflects the progress and evolution of healthcare communication in the Australian pharmaceutical and life science industry.
News & Trends - Pharmaceuticals

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board
Pharma News: Professor John Skerritt has been appointed as an Independent Selected Director on the Medicines Australia Board effective 4 […]
MoreNews & Trends - MedTech & Diagnostics

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech
MedTech & Diagnostics News: In a move aimed at enhancing cystic fibrosis (CF) care and support, Australian-based medical device company, […]
MoreNews & Trends - Pharmaceuticals

Does the evidence support safety concerns following CAR-T cell therapies?
Pharma News: The U.S. Food and Drug Administration (FDA) has launched an investigation into a concerning risk associated with CAR-T […]
More